Company Search:
Advanced Search
Sponsored Links
Genexine Inc Company Snapshot
Genexine Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genexine Inc with three other companies in this sector in South Korea: iNtRON Biotechnology Inc (2016 sales of 10.22 billion Korean Won [US$9.34 million] of which 100% was Genetic reagent division), Crystalgenomics Incorporation (14.52 billion Korean Won [US$13.28 million] of which 100% was Biotechnology), and Dna Link Inc (11.48 billion Korean Won [US$10.50 million] ).

Sales Analysis. Genexine Inc reported sales of 11.35 billion Korean Won (US$10.38 million) for the year ending December of 2016. This represents a sharp decrease of 65.1% versus 2015, when the company's sales were 32.52 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Genexine Inc
  Stock Performance Chart for Genexine Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 53,300
(Figures in Korean Won)
1 Week -10.9%   13 Weeks 6.8%  
4 Weeks 9.9%   52 Weeks 30.2%  
Genexine Inc Key Data:
  Ticker: 095700 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 11,351,915,014
(Year Ending Jan 2017).
Employees: 77
  Currency: Korean Won Market Cap: 1,017,739,728,200
  Fiscal Yr Ends: December Shares Outstanding: 19,094,554
  Share Type: Closely Held Shares: 6,623,845
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.